0001144204-11-019353.txt : 20110331 0001144204-11-019353.hdr.sgml : 20110331 20110331211711 ACCESSION NUMBER: 0001144204-11-019353 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110325 FILED AS OF DATE: 20110331 DATE AS OF CHANGE: 20110331 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Brusegard David CENTRAL INDEX KEY: 0001516920 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-25169 FILM NUMBER: 11728484 MAIL ADDRESS: STREET 1: 33 HARBOUR SQUARE CITY: TORONTO STATE: A6 ZIP: M5J 2G2 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENEREX BIOTECHNOLOGY CORP CENTRAL INDEX KEY: 0001059784 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 820490211 STATE OF INCORPORATION: DE FISCAL YEAR END: 0731 BUSINESS ADDRESS: STREET 1: 33 HARBOUR SQ STREET 2: STE 202 CITY: TORONTO ONTARIO CANADA STATE: A1 ZIP: M5J 2G2 BUSINESS PHONE: 4163642551 MAIL ADDRESS: STREET 1: 33 HARBOUR SQ STREET 2: STE 202 CITY: TORONTO ONTARIO CA STATE: A1 ZIP: M5J 2G2 3 1 v217161_ex.xml X0203 3 2011-03-25 0 0001059784 GENEREX BIOTECHNOLOGY CORP GNBT 0001516920 Brusegard David C/O GENEREX BIOTECHNOLOGY CORPORATION 33 HARBOUR SQUARE, SUITE 202 TORONTO A6 M5J 2G2 ONTARIO, CANADA 0 1 0 0 Chief Operating Officer Common Stock 31295 D Common Stock Option (right to buy) 0.282 2011-03-25 2016-03-25 Common Stock 200000 D /s/ David A. Brusegard 2011-03-31